On March 8, 2023 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported that it will release fourth quarter and full year 2022 financial results before the market opens on Wednesday, March 15, 2023 (Press release, Hookipa Biotech, MAR 8, 2023, View Source [SID1234628305]). The Company will host a live conference call and webcast at 8:30 AM ET to discuss its financial results and provide a corporate update.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call & Webcast:
Date: March 15, 2023
Time: 8:30 AM ET
USA Dial In: +1-800-715-9871
UK Dial In: 0800-260-6466
Austria Dial In: +43 800-070-441
Conference ID: 7669853
Webcast: Link
The webcast and the presentation will also be available within the Investors & Media section of HOOKIPA’s website at View Source